findmyKOL
Clinical trialNCT04456153CompletedPhase 2Interventional

Atovaquone for Treatment of COVID-19

SponsorUniversity of Texas Southwestern Medical CenterEnrollment60COVID-19
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Amneris Luque, M.D.

    University of Texas Southwestern Medical Center

    Principal Investigator
  • Ezimamaka Ajufo, M.D.

    University of Texas Southwestern Medical Center

    Principal Investigator
  • Helen King, M.D.

    University of Texas Southwestern Medical Center

    Principal Investigator
  • Hesham Sadek, M.D.

    University of Texas Southwestern Medical Center

    Principal Investigator
  • James De Lemos, M.D.

    University of Texas Southwestern Medical Center

    Principal Investigator
  • Jessica Meisner, M.D.

    University of Texas Southwestern Medical Center

    Principal Investigator
  • John Schoggins, Ph.D.

    University of Texas Southwestern Medical Center

    Principal Investigator
  • Mamta Jain, M.D.

    University of Texas Southwestern Medical Center

    Principal Investigator
  • Reuben Arasaratnam, M.D.

    University of Texas Southwestern Medical Center

    Principal Investigator
  • Satish Mocherla, M.D.

    University of Texas Southwestern Medical Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Texas Medical Center

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Jul 2020
Primary completion
31 Jan 2021
Completion
31 Jan 2021
Last update posted
14 Dec 2021
Registered enrollment
60
Registry id
NCT04456153

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.